Connor, Clark & Lunn Investment Management (CC&L)’s Elanco Animal Health ELAN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	95,381 +56,975	+148%	+$1.32M	﹤0.01%	960
2026 Q1	$919K	Buy	+38,406	New	+$939K	﹤0.01%	1179
2025 Q3	–	Sell	-279,124	Closed	-$3.99M	–	1551
2025 Q2	$3.99M	Buy	+279,124	New	+$3.26M	0.01%	648
2025 Q1	–	Sell	-53,830	Closed	-$652K	–	1465
2024 Q4	$652K	Buy	+53,830	New	+$704K	﹤0.01%	1073
2024 Q1	–	Sell	-388,459	Closed	-$5.79M	–	1565
2023 Q4	$5.79M	Sell	388,459 -58,888	-13%	-$667K	0.03%	383
2023 Q3	$5.03M	Sell	447,347 -52,045	-10%	-$604K	0.03%	401
2023 Q2	$5.02M	Buy	499,392 +218,476	+78%	+$2.03M	0.03%	400
2023 Q1	$2.64M	Buy	+280,916	New	+$3.31M	0.01%	498
2020 Q4	–	Sell	-51,723	Closed	-$1.45M	–	937
2020 Q3	$1.45M	Buy	+51,723	New	+$1.31M	0.01%	542
2019 Q3	–	Sell	-33,000	Closed	-$1.11M	–	989
2019 Q2	$1.11M	Buy	33,000 +500	+2%	+$16.2K	0.01%	547
2019 Q1	$1.04M	Buy	+32,500	New	+$1M	0.01%	526

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ELAN Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Elanco Animal Health (ELAN) stake by 148% in Q2 2026, buying an estimated $1.32M and bringing the position to 95,381 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ELAN in Q1 2019 and has held it in 11 quarters since. The position peaked at $5.79M in Q4 2023. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 95,381 shares of Elanco Animal Health worth $2.35M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 56,975 Elanco Animal Health shares in Q2 2026, an estimated $1.32M.
Elanco Animal Health made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #960 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Elanco Animal Health in Q1 2019 and has held it in 11 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Elanco Animal Health position peaked at $5.79M in Q4 2023.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.